Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches
M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
Transforming growth factor-beta (TGF-β) plays multiple homeostatic roles in the regulation of
inflammation, proliferation, differentiation and would healing of various tissues. Many studies …
inflammation, proliferation, differentiation and would healing of various tissues. Many studies …
Absorption, distribution, metabolism, and excretion of US Food and Drug Administration–Approved antisense oligonucleotide drugs
JM Migliorati, S Liu, A Liu, A Gogate, S Nair… - Drug Metabolism and …, 2022 - ASPET
Absorption, distribution, metabolism, and excretion (ADME) are the key biologic processes
for determination of a drug's pharmacokinetic parameters, which have direct impacts on …
for determination of a drug's pharmacokinetic parameters, which have direct impacts on …
[HTML][HTML] RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
Traditionally majority of eukaryotic gene expression is influenced by transcriptional and post-
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …
transcriptional events. Alterations in the expression of proteins that act post-transcriptionally …
[HTML][HTML] Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies
A Mehmandar-Oskuie, K Jahankhani… - Biomedicine & …, 2023 - Elsevier
Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …
Modification of lipid-based nanoparticles: An efficient delivery system for nucleic acid-based immunotherapy
Lipid-based nanoparticles (LBNPs) are biocompatible and biodegradable vesicles that are
considered to be one of the most efficient drug delivery platforms. Due to the prominent …
considered to be one of the most efficient drug delivery platforms. Due to the prominent …
[HTML][HTML] Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols.
Liposomes are nano-sized lipid-based vesicles widely studied for their drug delivery
capabilities. Compared to standard carries they exhibit better properties such as improved …
capabilities. Compared to standard carries they exhibit better properties such as improved …
local tumor necrosis factor-α inhibition in inflammatory bowel disease
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD)
characterized by intestinal inflammation. Increased intestinal levels of the proinflammatory …
characterized by intestinal inflammation. Increased intestinal levels of the proinflammatory …
Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing
Lipid nanoparticles (LNPs) are gaining traction in the field of nucleic acid delivery following
the success of two mRNA vaccines against COVID-19. As one of the constituent lipids on …
the success of two mRNA vaccines against COVID-19. As one of the constituent lipids on …
Internal ribosome entry site (IRES)-mediated translation and its potential for novel mRNA-based therapy development
R Marques, R Lacerda, L Romão - Biomedicines, 2022 - mdpi.com
Many conditions can benefit from RNA-based therapies, namely, those targeting internal
ribosome entry sites (IRESs) and their regulatory proteins, the IRES trans-acting factors …
ribosome entry sites (IRESs) and their regulatory proteins, the IRES trans-acting factors …